Cannabis Research Buds Out in New Directions, Arthritis to Insomnia
Debra Kamin, This Week at UC San Diego News, October 10, 2019
With 33 states and the District of Columbia having legalized medical marijuana, it was inevitable that there would be much talk of its therapeutic benefits, real or imagined. But lost in the equally inevitable hype has been hard scientific proof.
For almost two decades, the Center for Medicinal Cannabis Research (CMCR) at UC San Diego has been conducting such research, for much of that time largely alone and often, given the controversial nature of the subject, with limited resources. But times are changing, and CMCR recently announced a first wave of five new grants worth a total of $3 million to explore the efficacy and safety of medical cannabis as a supplementary or alternative treatment for schizophrenia, rheumatoid arthritis, insomnia, alcohol dependence and anxiety linked to anorexia.